Table 3

Summary of clinical and laboratory data in patients who developed Addison's disease after initial diagnosis of X-ALD

Patient (age)*Significant past historyClinical features at diagnosis of ALDVLCFA (C26, μmol/l)Subsequent clinical courseAge at diagnosis of Addison's diseasePeak cortisol (nmol/l)ACTH (ng/l)Renin (pmol/ml/h)
*Age at diagnosis of ALD.
G (14 y)UnremarkableSchool failure with poor handwriting and drawing, hyperactive, neurological deterioration, coordination problems, and memory loss2.86Developed Addison's disease 6 mth later, rapid neurological deterioration, died aged 17 y14.626918412
H (1.6 y)UnremarkableFamily history of ALD in sibling1.71Developed Addison's disease 6 mth later, MRI and neuropsychology normal at 10 y of age2 y2301083.8
I (15 y)UnremarkableSchool failure, impaired vision, behavioural problems3.50Slowly progressive form of C-ALD, manages self care, on carbamazepine for generalised epilepsy; developed Addison's disease 3 y later18 y4902271.8
J (5.5 y)UnremarkableFamily history of X-AMN in maternal uncles3.41Developed Addison's disease 5 y later; progressive neurological deterioration with ataxia, visual problems, memory loss, severely handicapped aged 16 y10.5 y4471472.1
K (3 y)Accidental skull fracture at 6 mth, has residual left sided hemiplegiaFamily history of X-AMN2.86Diffuse MRI changes consistent with previous head injury, neuropsychological performance stable at 12 y; developed Addison's disease 3 y later6 y3861631.8